Prime Medicine News - PRME

Company Name	Stock Ticker Symbol	Market	Type
Prime Medicine Inc	PRME	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.01	-0.23%	4.29	08:49:38

Open Price	Low Price	High Price	Close Price	Prev Close
				4.30

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	8:52	IHNW	FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/23/2024	08:00	GLOBE	Prime Medicine to Present Preclinical Data Demonstrating..
3/01/2024	08:09	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
3/01/2024	08:04	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/01/2024	08:01	EDGAR2	Form 8-K - Current report
3/01/2024	08:00	GLOBE	Prime Medicine Reports Full Year 2023 Financial Results and..
2/28/2024	08:00	GLOBE	Prime Medicine to Participate in Upcoming Investor..
2/23/2024	17:03	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/23/2024	17:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/22/2024	21:31	EDGAR2	Form SC 13D - General statement of acquisition of beneficial..
2/20/2024	17:38	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/20/2024	16:01	GLOBE	Prime Medicine Announces Closing of Upsized Public Offering..
2/16/2024	06:23	EDGAR2	Form 8-K - Current report
2/16/2024	06:17	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2/14/2024	23:50	GLOBE	Prime Medicine Announces Pricing of Upsized Public Offering
2/14/2024	21:57	EDGAR2	Form FWP - Filing under Securities Act Rules 163/433 of free..
2/14/2024	17:27	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2/14/2024	16:12	EDGAR2	Form 8-K - Current report
2/14/2024	16:05	GLOBE	Prime Medicine Announces Proposed Public Offering of Common..
1/25/2024	08:00	GLOBE	Prime Medicine Receives Up to $15 Million from Cystic..
1/08/2024	08:01	EDGAR2	Form 8-K - Current report
1/05/2024	17:03	EDGAR2	Form 8-K - Current report
1/05/2024	08:15	EDGAR2	Form 8-K - Current report
1/05/2024	08:00	GLOBE	Prime Medicine Appoints Allan Reine, M.D., as Chief..
1/02/2024	08:00	GLOBE	Prime Medicine to Present at 42nd Annual J.P. Morgan..
11/14/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
11/08/2023	08:00	GLOBE	Prime Medicine to Present at Upcoming Investor Conferences
11/03/2023	17:23	EDGAR2	Form S-3 - Registration statement under Securities Act of..
11/03/2023	17:09	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/03/2023	16:06	EDGAR2	Form 8-K - Current report
11/03/2023	16:01	GLOBE	Prime Medicine Reports Third Quarter 2023 Financial Results..
10/27/2023	06:00	GLOBE	Prime Medicine Presents First-ever Prime Editing Data in..
10/24/2023	07:30	GLOBE	Prime Medicine Presents First In Vivo Proof-of-Concept Prime..
10/17/2023	08:00	GLOBE	Prime Medicine to Highlight Positive Preclinical..
9/19/2023	08:00	GLOBE	Prime Medicine to Present at Upcoming Investor Conferences
8/31/2023	08:00	GLOBE	Prime Medicine to Present at Upcoming Investor Conferences
8/07/2023	16:09	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/2023	16:04	EDGAR2	Form 8-K - Current report
8/07/2023	16:01	GLOBE	Prime Medicine Reports Second Quarter 2023 Financial Results..
6/22/2023	08:00	GLOBE	Prime Medicine and Cimeio Therapeutics Announce Research..
5/31/2023	08:00	GLOBE	Prime Medicine to Present at Investor Conferences in June
5/17/2023	16:05	GLOBE	Prime Medicine to Present at Virtual Investor Conferences in..
5/17/2023	06:00	GLOBE	Prime Medicine to Present New Preclinical Data Highlighting..
5/11/2023	08:00	GLOBE	Prime Medicine Reports First Quarter 2023 Financial Results..